Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Stock Crosses Above Fifty Day Moving Average – What’s Next?

Bayer Aktiengesellschaft (OTCMKTS:BAYRYGet Free Report) shares crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $5.16 and traded as high as $5.47. Bayer Aktiengesellschaft shares last traded at $5.43, with a volume of 683,003 shares traded.

Bayer Aktiengesellschaft Price Performance

The firm has a market cap of $21.34 billion, a price-to-earnings ratio of -20.88 and a beta of 1.02. The company has a quick ratio of 0.81, a current ratio of 1.32 and a debt-to-equity ratio of 1.19. The company’s 50-day moving average price is $5.14 and its 200-day moving average price is $6.64.

Bayer Aktiengesellschaft (OTCMKTS:BAYRYGet Free Report) last announced its earnings results on Tuesday, November 12th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.10). The business had revenue of $10.96 billion for the quarter. Bayer Aktiengesellschaft had a positive return on equity of 16.90% and a negative net margin of 2.02%. On average, equities research analysts forecast that Bayer Aktiengesellschaft will post 1.31 EPS for the current year.

About Bayer Aktiengesellschaft

(Get Free Report)

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.

Featured Stories

Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.